Skip to Main Content

Paper Details

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis.
Blood Cancer J
34
2015
Author NameAffiliation
Ola MyklebostInstitute for Cancer Research, Radium Hospital, Oslo University Hospital
Eivind HovigInstitute for Cancer Research, Radium Hospital, Oslo University Hospital, Norway [3] Institute for Cancer Genetics and Informatics, University of Oslo
Sigve NakkenInstitute for Cancer Research, Radium Hospital, Oslo University Hospital
Daniel Vod??kInstitute for Cancer Research, Radium Hospital, Oslo University Hospital
  • 1 - 4

Datasets

Release 1.2